NEUROPACE INC Share Price Today: Live Updates & Key Insights

NEUROPACE INC share price today is $13, up -0.99%. The stock opened at $12.91 against the previous close of $13.13, with an intraday high of $13.19 and low of $12.71.

NEUROPACE INC Share Price Chart

NEUROPACE INC

us-stock
To Invest in {{usstockname}}
us-stock

NEUROPACE INC Share Price Performance

$13 -0.0099(-0.99%) NPCE at 23 Mar 2026 02:29 PM Medical Devices
Lowest Today 12.71
Highest Today 13.19
Today’s Open 12.91
Prev. Close 13.13
52 Week High 18.98
52 Week Low 7.56
Day’s Range: Low 12.71 High 13.19
52-Week Range: Low 7.56 High 18.98
1 day return -
1 Week return -8.24
1 month return -10.45
3 month return -21.42
6 month return +25.43
1 year return +6.19
3 year return +246.27
5 year return -47.81
10 year return -

NEUROPACE INC Institutional Holdings

Soleus Capital Management, L.P. 8.79

Polar Capital Holdings PLC 8.55

Polar Capital Healthcare Opports Inc 8.32

Morgan Stanley - Brokerage Accounts 7.56

BlackRock Inc 7.18

Orbimed Advisors, LLC 7.15

Driehaus Capital Management LLC 4.49

Vanguard Group Inc 4.40

First Light Asset Management, LLC 4.01

Kent Lake PR LLC 2.97

Deutsche Bank AG 2.76

Vanguard Total Stock Mkt Idx Inv 2.46

Armistice Capital, LLC 2.35

Xtrackers MSCI World Swap ETF 1C 2.19

FMR Inc 1.86

iShares Russell 2000 ETF 1.83

Geode Capital Management, LLC 1.77

Heptagon Driehaus US Micro Cap Eq C$ Acc 1.35

Fidelity Small Cap Growth 1.22

State Street Corp 1.21

Silvercrest Asset Management Group LLC 1.18

Polar Capital Glb Healthcare Ord 1.11

Nantahala Capital Management, LLC 0.88

Divisadero Street Capital Management, LP 0.87

Vanguard Institutional Extnd Mkt Idx Tr 0.79

Fidelity Small Cap Index 0.74

Northern Trust Corp 0.70

BlackRock Advantage Small Cap Core Instl 0.68

Walleye Trading Advisors, LLC 0.68

Renaissance Technologies Corp 0.66

iShares Russell 2000 Growth ETF 0.63

Fidelity Small Cap Growth K6 0.61

Driehaus Micro Cap Growth USD 0.52

Driehaus Micro Cap Growth USD 0.52

Xtrackers S&P 500 Swap ETF 1C 0.50

Fidelity Extended Market Index 0.38

Vanguard Russell 2000 ETF 0.36

State St Russell Sm/Mid Cp® Indx SL Cl I 0.36

Silvercrest U.S. Small Cap Growth 0.35

Lazard US Small Cap Equity WW Dist EUR 0.29

NEUROPACE INC Market Status

Strong Buy: 6

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

NEUROPACE INC Fundamentals

Market Cap 437.67 M

PB Ratio 22.9978

PE Ratio 0.0

Enterprise Value 447.45 M

Total Assets 105.57 M

Volume 301919

NEUROPACE INC Company Financials

Annual Revenue FY23:65421000 65.4M, FY22:45520000 45.5M, FY21:45183000 45.2M, FY20:41138000 41.1M, FY19:36972000 37.0M

Annual Profit FY23:48122000 48.1M, FY22:32493000 32.5M, FY21:33435000 33.4M, FY20:30272000 30.3M, FY19:26464000 26.5M

Annual Net worth FY23:-32956000 -33.0M, FY22:-53370000 -53.4M, FY21:-38109000 -38.1M, FY20:-35982000 -36.0M, FY19:-40740000 -40.7M

Quarterly Revenue Q3/2025:27354000 27.4M, Q2/2025:23520000 23.5M, Q1/2025:22524000 22.5M, Q3/2024:21060000 21.1M, Q2/2024:19256000 19.3M

Quarterly Profit Q3/2025:21168000 21.2M, Q2/2025:18132000 18.1M, Q1/2025:17342000 17.3M, Q3/2024:15420000 15.4M, Q2/2024:14134000 14.1M

Quarterly Net worth Q3/2025:-3496000 -3.5M, Q2/2025:-8651000 -8.7M, Q1/2025:-6589000 -6.6M, Q3/2024:-5452000 -5.5M, Q2/2024:-7514000 -7.5M

About NEUROPACE INC & investment objective

Company Information NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Organisation Medical Devices

Employees 209

Industry Medical Devices

CEO Mr. Joel D. Becker

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

NEUROPACE INC FAQs

What is the share price of NEUROPACE INC today?

The current share price of NEUROPACE INC is $13.

Can I buy NEUROPACE INC shares in India?

Yes, Indian investors can buy NEUROPACE INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy NEUROPACE INC shares in India?

You can easily invest in NEUROPACE INC shares from India by:

Can I buy fractional shares of NEUROPACE INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of NEUROPACE INC?

NEUROPACE INC has a market cap of $437.67 M.

In which sector does NEUROPACE INC belong?

NEUROPACE INC operates in the Medical Devices sector.

What documents are required to invest in NEUROPACE INC stocks?

To invest, you typically need:

What is the PE and PB ratio of NEUROPACE INC?

The PE ratio of NEUROPACE INC is N/A and the PB ratio is 23.00.